Molson Coors Beverage Company is expanding its US non-alc portfolio through a new strategic partnership with Fevertree Drinks plc, a supplier of premium carbonated drinks and mixers.

Molson Coors assumes exclusive commercialization rights to Fever-Tree’s award-winning lineup of tonics, ginger beers, cocktail mixers and more in the US and will be responsible for co-manufactured production, marketing, sales and distribution of the brand in the US. The move is a significant step forward in Molson Coors’ strategic ambition to build a total-beverage portfolio for a wide range of consumer preferences across traditional alcohol occasions and non-alc occasions alike.

Molson Coors plans to build on the position Fever-Tree has already established in the US by leveraging its core strengths, commercial scale and supply chain expertise to expand distribution, grow brand awareness, and create a solid runway for long-term growth in the US market.

Underpinning the partnership and reflecting Molson Coors’ long-term focus on – and belief in – the opportunity, the company has agreed to acquire an 8.5% stake in Fevertree Drinks plc, resulting in Molson Coors becoming Fever-Tree’s second largest shareholder.

The partnership with Fever-Tree builds on Molson Coors’ strong recent momentum in the advancement of its Beyond Beer and premiumization strategy. The company took a majority stake in ZOA Energy in November 2024 and has since expanded distribution into new accounts and channels. Additionally, Molson Coors is preparing to bring Naked Life, Australia’s #1 non-alc RTD cocktail, to the US this spring.

Molson Coors and Fever-Tree’s strategic partnership is subject to customary closing conditions.